Today, many companies aggressively market testosterone therapy products to middle-aged men. From these ads, you may learn that certain gels, patches and injections can be prescribed to treat “low T” and symptoms such as unusual depression, reduced energy and low sex drive.
What you likely won’t learn from these ads is that the U.S. Food and Drug Administration (FDA) is now investigating prescribed testosterone therapy products. The FDA is acting in response to studies that have found a higher risk of strokes, heart attacks and deaths that may be linked to these products.
If you or a loved one is a male who has experienced cardiovascular problems after using testosterone therapy products, Techmeier Law Firm wants to help you. Contact us today. Our dangerous drug lawyers are closely reviewing these cases in Milwaukee and across Wisconsin. We can offer a free evaluation and explain the legal options available to you.
Studies Link Higher Risk of Strokes, Heart Attacks and Deaths to Testosterone Products
The FDA has approved testosterone products for men who have “low T” levels due to an associated medical condition such as one that may be related to genetics or chemotherapy.
According to one recent study, the number of men over age 40 who are taking prescribed testosterone products has tripled over the past decade. Marketing and the growing number of low testosterone clinics or “low T centers” have driven this growth, the study found.
Commonly prescribed “low T” products include Androderm, AndroGel, Axiron, Fortesta, Testopel, Striant, Delatestryl and Testim. They are available as skin patches, mouth patches, gels and injections.
However, in a January 31, 2014 safety announcement, the FDA said it would launch an investigation into the potential stroke and heart attack risks that these products may pose.
The FDA reported that two studies prompted its investigation:
- One study was published in the Journal of the American Medical Association in November 2013. The men analyzed in the study were, on average, age 60 or older and had an underlying cardiovascular disease. Researchers found that these men experienced a 30 percent higher risk of stroke, heart attack and death when prescribed testosterone therapy products, according to the FDA.
- Another study was published online in January 2014 in the online journal PLOS ONE. In that study, researchers found a two-fold increase in the risk of heart attack among men ages 65 and older within the first 90 days of being prescribed testosterone. The risk during that same time span was two-to-three times higher in men under age 65 with a history of heart disease, the FDA reported.
The FDA has not concluded that these “low T” products increase the risk of strokes, heart attacks and “other cardiovascular dangers.”
However, at least one group, Public Citizen, has called on the FDA to go forward immediately with requiring a “black box” warning on the products’ labels about these risks – the strongest warning possible.
What Can You Do If You Have Cardiovascular Problems After Taking ‘Low T’ Products?
If you or someone close to you is a male in Milwaukee or elsewhere in Wisconsin who has suffered cardiovascular health problems after using a “low T” product, you should consult with your doctor immediately.
You should also contact a lawyer with a background in handling dangerous drug claims. The lawyer can review your case closely and determine whether you have a claim that may be based on:
- Defective design or manufacture of these products
- Failure to properly warn of the products’ stroke, heart attack and death risks.
Because millions of men across the country may be impacted, litigation could become highly complex. It is crucial to work with a law firm that has the skill, experience and resources to handle your case.
Techmeier Law Firm is ready to assist you. Please contact us without delay.
For More Information
• For Some Men, It’s ‘T’ Time – Test or No Test, University of Texas Medical Branch
• Is Testosterone Replacement Therapy Right for You? WebMd
• FDA Evaluating Risk of Stroke, Heart Attack and Death with FDA-Approved Testosterone Products, U.S. Food and Drug Administration
• Public Citizen Petitions FDA for a Black Box Warning on Testosterone Products, Public Citizen